Abstract

Sepsis-associated liver dysfunction presents a significant public health problem. 6-Shogaol is the key bioactive component in dry ginger, which has antioxidant and anti-inflammation capacity. The present study aims to investigate the preventive effect of 6-shogaol on sepsis-induced liver injury. 6-Shogaol was administered to mice for 7 consecutive days before being intraperitoneally injected with lipopolysaccharide (LPS). After 24 h, mice were sacrificed, and biochemical and transcriptomic analyses were performed. Our results demonstrated that 6-shogaol prevented LPS-induced impairment in antioxidant enzymes and elevation in malondialdehyde level in the liver. The hepatic inflammatory response was significantly suppressed by 6-shogaol through suppressing the MAPK/NFκB pathway. RNA-sequencing data analysis revealed that 41 overlapped genes between the LPS vs. control group and 6-shogaol vs. LPS group were identified, among which 36 genes were upregulated, and 5 genes were downregulated for the LPS vs. control group. These overlapped genes are enriched in inflammation-related pathways, e.g., TNF and NFκB. The mRNA expression of the overlapped genes was also verified in the LPS-induced BRL-3A cell model. In summary, 6-shogaol shows great potential as a natural chemopreventive agent to treat sepsis-associated hepatic disorders.

Highlights

  • Sepsis is a systematic inflammatory response caused mainly by bacteria

  • Primary antibodies against β-actin, IκBα, phosphoIκBα(Ser32), p65, phospho-p65(Ser536), and secondary antibody horseradish peroxidase (HRP)-linked anti-rabbit antibody were purchased from Cell Signaling Technology (Danvers, MA, USA)

  • MAPK by significantly elevating the phosphorylation of JNK and ERK, thereby caused degradation of IκBα and triggered the phosphorylation of p65 (p < 0.01). All these changes were markedly reversed by treatment with 6-shogaol (p < 0.05 and p < 0.01). These results indicate that 6-shogaol regulated hepatic inflammation through MAPK/NFκB pathway

Read more

Summary

Introduction

Sepsis is a systematic inflammatory response caused mainly by bacteria. It is one of the most life-threatening illnesses among intensive care patients worldwide [1]. It has been demonstrated that patients with sepsis and early liver dysfunction exhibited significantly elevated mortality and poor prognosis [8]. 6-Shogaol attenuates neuroinflammation and cognitive deficits in animal models of dementia [15]. It has been reported as the most potent anti-inflammatory and anti-oxidant component in ginger [18]. We hope that this study will provide candidate targets for treating endotoxin-related hepatic disorders, as well as evidence for the therapeutic application of 6-shogaol for inflammatory liver diseases in the future

Reagents
Animals
Biochemical Analysis
Histological Analysis
RNA-Sequencing Detection
Bioinformatics Analysis
Cell Culture and Treatment
Quantitative Real-Time PCR Analysis for mRNA Expression
Western Blot Analysis for Protein Expression
Results
Transcriptional Response in the Liver after 6-Shogaol Treatment
Gene Functional Analysis
Findings
Discussion
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call